CVS — CVS HEALTH CORP

Ownership history in Altrafin AG  ·  1 quarter on record

This page tracks every 13F SEC filing in which Altrafin AG reported a position in CVS HEALTH CORP (CVS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.47% (2025 Q4)
Avg. % of fund
3.47%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 93,152 — — 3.47% $9.6M $78.71
% of Fund (quarterly)    CVS price (monthly, adj. close)

Other funds also holding CVS

As of 2025 Q4 — sorted by position size

Watchtower Advisors, LP 3Y 17.11% GLENVIEW CAPITAL MANAGEMENT, LLC 3Y 7Y 13.24% FAIRFAX FINANCIAL HOLDINGS LTD/ CAN 3Y 7Y 10.33% Solel Partners LP 3Y 7.62% Kiltearn Partners LLP 3Y 7Y 7.59% Chieftain Capital Management, Inc. 3Y 7Y 6.9% EDGAR LOMAX CO/VA 3Y 7Y 5.5% COLRAIN CAPITAL LLC 3Y 7Y 5.34% Sachem Head Capital Management LP 3Y 7Y 4.81% 8 KNOTS MANAGEMENT, LLC 4.71%
← Back to Altrafin AG Holdings